ArticleMediterranean journal of hematology and infectious diseases2022

Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation.

Claudio Ucciferri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.